Global Biologic Therapeutics Industrial and Market studies 2016-2019
"Global Biologic Therapeutics Market 2015-2019" The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect.
Description-
About biologic therapeutics
Biologic therapeutics include virus, therapeutic serums, toxins, allergenic products, antitoxin, blood components or derivatives, vaccines, blood, and proteins (except any chemically synthesized polypeptide). They also include analogous products, arsphenamine, or derivatives of arsphenamine (or any other trivalent organic arsenic compound) for the prevention, treatment, or cure of a disease. The differences between the biologics and small molecules include the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex molecular structure. They are usually derived from living entities, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures (thermolabile) and light.
Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=437782
Covered in this report
This report covers the present scenario and the growth prospects of the global biologic therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics).
Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
Technavio's report, Global Biologic Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global biologic therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Amgen
F. Hoffmann-La Roche
Novo Nordisk
Sanofi
Other prominent vendors
AbbVie
AstraZeneca
Bavarian Nordic
Baxter International
Beijing Minhai Biotechnology
Bharat Biotech
Bharat Immunologicals and Biologicals
Bio Med Pvt.
bioCSL
Biodel
Bristol-Myers Squibb
Diamyd Medical
DiaVacs
Dynavax Technologies
Eli Lilly
Generex Biotechnology
Hualan Biological Engineering
Imunoloski Zavod
Indian Immunologicals
Janssen
JN International Medical
Kaketsuken
LG Life Sciences
Macrogenics
MannKind
Merck
Mitsubishi Tanabe Pharma
Nuron Biotech
Osiris Therapeutics
Pfizer
Protalix
Protein Sciences
Serum Institute of India
Shenzhen Kangtai Biological Products
Sinovac Biotech
Tolerion
Vacunas Finlay
XOMA
Zydus Cadila
Market driver
Reimbursement support for biologics
For a full, detailed list, view our report
Market challenge
High cost of therapy
For a full, detailed list, view our report
Market trend
Emergence of targeted and combination therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?